Morphic Therapeutic develops and commercializes oral integrin drugs for the treatment of immunological, fibrotic and neoplastic diseases.Read more
Galectin is perceived as one of Morphic Therapeutic's biggest rivals. Galectin was founded in 2000, and is headquartered in Norcross, Georgia. Galectin is in the Pharmaceuticals industry. Galectin generates $41.6M less revenue vs. Morphic Therapeutic.
Indalo Therapeutics is a top competitor of Morphic Therapeutic. Indalo Therapeutics is a Private company that was founded in 2014 in Cambridge, Massachusetts. Like Morphic Therapeutic, Indalo Therapeutics also operates in the Health Care Services space. Compared to Morphic Therapeutic, Indalo Therapeutics has 56 fewer employees.
Morphic Therapeutic's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 69.6M. Over the last four quarters, Morphic Therapeutic's revenue has decreased by 57.6%. Specifically, in Q1 2021's revenue was $3.3M; in Q4 2020, it was $5.9M; in Q3 2020, it was $25.8M; in Q2 2020, Morphic Therapeutic's revenue was $7.7M.
No recent acquisitions found related to Morphic Therapeutic
No recent investments found related to Morphic Therapeutic